Stephen Willey
Stock Analyst at Stifel
(3.99)
# 578
Out of 5,081 analysts
126
Total ratings
43.01%
Success rate
15.05%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stephen Willey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZYME Zymeworks | Maintains: Buy | $30 → $40 | $26.22 | +52.56% | 7 | Nov 19, 2025 | |
| CELC Celcuity | Maintains: Buy | $68 → $115 | $100.00 | +15.00% | 2 | Nov 13, 2025 | |
| NKTX Nkarta | Maintains: Buy | $12 → $11 | $1.78 | +517.98% | 5 | Nov 11, 2025 | |
| IRON Disc Medicine | Reinstates: Buy | $125 | $92.28 | +35.46% | 1 | Nov 3, 2025 | |
| ACLX Arcellx | Reinstates: Buy | $129 | $72.94 | +76.86% | 1 | Oct 16, 2025 | |
| INCY Incyte | Maintains: Buy | $110 → $115 | $101.50 | +13.30% | 7 | Sep 22, 2025 | |
| XFOR X4 Pharmaceuticals | Maintains: Buy | $30 → $9 | $3.25 | +176.92% | 3 | Aug 29, 2025 | |
| INSM Insmed | Maintains: Buy | $121 → $145 | $206.78 | -29.88% | 8 | Aug 14, 2025 | |
| ABCL AbCellera Biologics | Maintains: Buy | $8 → $7 | $3.48 | +101.15% | 7 | Aug 8, 2025 | |
| EXEL Exelixis | Maintains: Hold | $38 → $41 | $44.01 | -6.84% | 19 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $13.37 | +109.42% | 1 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6 → $5 | $1.40 | +257.14% | 4 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $25 → $20 | $5.36 | +273.13% | 4 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $35 | $16.83 | +107.96% | 5 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $100 | $8.51 | +1,075.09% | 5 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $1.27 | +214.96% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $18.16 | +158.81% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $0.56 | +614.16% | 7 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $1.57 | +154.78% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $62 | $44.28 | +40.02% | 5 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $5.28 | +70.45% | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.88 | +538.30% | 1 | Nov 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $228 → $288 | $2.02 | +14,157.43% | 4 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $21 | $2.28 | +821.05% | 2 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $10 → $4 | $1.40 | +185.71% | 7 | Jul 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $123 | $473.29 | -74.01% | 3 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $48 → $47 | $81.84 | -42.57% | 2 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $102 → $109 | $54.31 | +100.70% | 3 | Aug 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Terminates: Hold | n/a | $20.86 | - | 2 | Jun 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $23 | $7.79 | +195.25% | 5 | Feb 7, 2018 |
Zymeworks
Nov 19, 2025
Maintains: Buy
Price Target: $30 → $40
Current: $26.22
Upside: +52.56%
Celcuity
Nov 13, 2025
Maintains: Buy
Price Target: $68 → $115
Current: $100.00
Upside: +15.00%
Nkarta
Nov 11, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $1.78
Upside: +517.98%
Disc Medicine
Nov 3, 2025
Reinstates: Buy
Price Target: $125
Current: $92.28
Upside: +35.46%
Arcellx
Oct 16, 2025
Reinstates: Buy
Price Target: $129
Current: $72.94
Upside: +76.86%
Incyte
Sep 22, 2025
Maintains: Buy
Price Target: $110 → $115
Current: $101.50
Upside: +13.30%
X4 Pharmaceuticals
Aug 29, 2025
Maintains: Buy
Price Target: $30 → $9
Current: $3.25
Upside: +176.92%
Insmed
Aug 14, 2025
Maintains: Buy
Price Target: $121 → $145
Current: $206.78
Upside: -29.88%
AbCellera Biologics
Aug 8, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $3.48
Upside: +101.15%
Exelixis
Jul 29, 2025
Maintains: Hold
Price Target: $38 → $41
Current: $44.01
Upside: -6.84%
Jun 25, 2025
Initiates: Buy
Price Target: $28
Current: $13.37
Upside: +109.42%
May 14, 2025
Maintains: Hold
Price Target: $6 → $5
Current: $1.40
Upside: +257.14%
May 13, 2025
Maintains: Hold
Price Target: $25 → $20
Current: $5.36
Upside: +273.13%
Apr 9, 2025
Maintains: Buy
Price Target: $36 → $35
Current: $16.83
Upside: +107.96%
Mar 21, 2025
Maintains: Buy
Price Target: $240 → $100
Current: $8.51
Upside: +1,075.09%
Feb 27, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.27
Upside: +214.96%
Oct 8, 2024
Initiates: Buy
Price Target: $47
Current: $18.16
Upside: +158.81%
Aug 20, 2024
Maintains: Buy
Price Target: $8 → $4
Current: $0.56
Upside: +614.16%
Dec 19, 2023
Maintains: Buy
Price Target: $3 → $4
Current: $1.57
Upside: +154.78%
Dec 18, 2023
Maintains: Buy
Price Target: $53 → $62
Current: $44.28
Upside: +40.02%
Jan 27, 2023
Initiates: Buy
Price Target: $9
Current: $5.28
Upside: +70.45%
Nov 28, 2022
Initiates: Buy
Price Target: $12
Current: $1.88
Upside: +538.30%
Jun 26, 2020
Downgrades: Hold
Price Target: $228 → $288
Current: $2.02
Upside: +14,157.43%
Mar 17, 2020
Maintains: Buy
Price Target: $22 → $21
Current: $2.28
Upside: +821.05%
Jul 29, 2019
Downgrades: Hold
Price Target: $10 → $4
Current: $1.40
Upside: +185.71%
Aug 13, 2018
Maintains: Buy
Price Target: $125 → $123
Current: $473.29
Upside: -74.01%
Aug 8, 2018
Maintains: Hold
Price Target: $48 → $47
Current: $81.84
Upside: -42.57%
Aug 3, 2018
Maintains: Buy
Price Target: $102 → $109
Current: $54.31
Upside: +100.70%
Jun 25, 2018
Terminates: Hold
Price Target: n/a
Current: $20.86
Upside: -
Feb 7, 2018
Maintains: Buy
Price Target: $20 → $23
Current: $7.79
Upside: +195.25%